ATG16L1 and colitis: Induction of remission was associated with the accumulation of colonic DCs expressing ATG16L1 in CD patients (Honjo et al., 2021), which was consistent with aggregated DSS-induced colitis in mice with DC-specific Atg16l1 deletion (Zhang et al., 2017; Honjo et al., 2021).